Xeljanz (Tofacitinib) Might Be Successful In Treating Sarcoidosis – Sarcoidosis News

Xeljanz is a partial inhibitor of the JAK enzyme that has been used off-label for the treatment of sarcoidosis and is being studied in clinical trials.
— Read on sarcoidosisnews.com/xeljanz-tofacitinib/